NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









LUCA Science

LUCA Science

Private
TokyoHealthcare & Life Scienceshttps://www.luca-science.com/

Last Round

Series B

Jun 6, 2022

Total Funding Raised

$40.1M

Company Overview

LUCA Science is a biotechnology company that develops functional mitochondria as therapeutic agents to treat damaged tissues and organs by enhancing and stabilizing mitochondrial activity.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

mitochondrial therapymitochondrial medicinecellular therapymitochondrial isolationregenerative medicinebiotech startupdrug discoverymitochondrial functionclinical developmentbiopharmamitochondrial diseasetherapeutic pipelinepreclinical research

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

LUCA Science Comparables

Compare LUCA Science with similar companies based on industry and business-model similarity.

LUCA Science comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
cellvie
81%
PAEAN Biotechnology
81%
Astellas Pharma Inc.
81%

LUCA Science Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BJun 6, 2022
Series AAug 31, 2020

Key People

Founding team and executive leadership

Yoshikazu Tokuoka

Chief Financial Officer

Executive Team

LUCA Science Investors

Notable investors and investment history

LUCA Science investors
InvestorRounds
Daiwa Securities GroupSeries B
Shinsei Capital PartnersSeries B
DCI PartnersSeries B
日本ベンチャーキャピタル株式会社Series B, Series A
Remiges VenturesSeries B, Series A
4BIO CapitalSeries B
Nissay CapitalSeries B

LUCA Science Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

LUCA Science Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about LUCA Science's valuation, stock price, and market status.

Firmographic Details

HeadquartersTokyo
Employee Range9
Year Founded2018
Last FundingJun 6, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.